| Primary |
| Antiretroviral Therapy |
48.3% |
| Hiv Infection |
27.6% |
| Prophylaxis Against Hiv Infection |
10.3% |
| Acquired Immunodeficiency Syndrome |
5.2% |
| Mucocutaneous Leishmaniasis |
3.4% |
| Infection Prophylaxis |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Toothache |
1.7% |
|
| Hypophosphataemia |
7.7% |
| Neutropenia |
7.7% |
| Renal Failure |
7.7% |
| Renal Failure Acute |
7.7% |
| Renal Tubular Disorder |
7.7% |
| Vanishing Bile Duct Syndrome |
7.7% |
| Blood Creatinine Increased |
3.8% |
| Death |
3.8% |
| Drug Toxicity |
3.8% |
| Hyponatraemia |
3.8% |
| Immune Reconstitution Inflammatory Syndrome Associated Kaposi's Sarcoma |
3.8% |
| Osteoporosis |
3.8% |
| Pyelocaliectasis |
3.8% |
| Renal Artery Stenosis |
3.8% |
| Renal Failure Chronic |
3.8% |
| Renal Impairment |
3.8% |
| Renal Injury |
3.8% |
| Rhabdomyolysis |
3.8% |
| Scapula Fracture |
3.8% |
| Thrombocytopenia |
3.8% |
|
| Secondary |
| Hiv Infection |
64.8% |
| Antiretroviral Therapy |
6.9% |
| Drug Use For Unknown Indication |
6.3% |
| Drug Exposure During Pregnancy |
3.6% |
| Prophylaxis |
2.8% |
| Product Used For Unknown Indication |
1.8% |
| Antifungal Prophylaxis |
1.7% |
| Diabetes Mellitus |
1.5% |
| Human Immunodeficiency Virus Transmission |
1.5% |
| Hiv Test Positive |
1.4% |
| Acquired Immunodeficiency Syndrome |
1.2% |
| Hepatitis C |
0.9% |
| Hypertension |
0.8% |
| Tuberculosis |
0.8% |
| Myocardial Infarction |
0.7% |
| Antiviral Treatment |
0.7% |
| Pyrexia |
0.7% |
| Pneumocystis Jiroveci Pneumonia |
0.6% |
| Insomnia |
0.6% |
| Systemic Antiviral Treatment |
0.5% |
|
| Vomiting |
13.0% |
| Drug Exposure During Pregnancy |
11.6% |
| Weight Decreased |
10.8% |
| Portal Hypertension |
5.3% |
| Renal Failure Acute |
5.3% |
| Renal Failure |
5.1% |
| Progressive External Ophthalmoplegia |
4.8% |
| Renal Tubular Necrosis |
4.8% |
| Myocardial Infarction |
4.6% |
| White Blood Cell Count Decreased |
4.2% |
| Lactic Acidosis |
4.0% |
| Pyrexia |
4.0% |
| Nephropathy Toxic |
3.7% |
| Premature Baby |
3.3% |
| Pregnancy |
2.9% |
| Splenomegaly |
2.9% |
| Sepsis |
2.6% |
| Pancreatitis |
2.4% |
| Renal Impairment |
2.4% |
| Staphylococcal Infection |
2.4% |
|
| Concomitant |
| Hiv Infection |
63.0% |
| Drug Use For Unknown Indication |
9.8% |
| Product Used For Unknown Indication |
4.0% |
| Hepatitis C |
2.7% |
| Antiretroviral Therapy |
2.7% |
| Diabetes Mellitus |
1.9% |
| Antibiotic Prophylaxis |
1.8% |
| Hypertension |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Prophylaxis |
1.4% |
| Depression |
1.3% |
| Antifungal Prophylaxis |
1.3% |
| Myocardial Infarction |
1.2% |
| Drug Exposure During Pregnancy |
1.0% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Asthma |
0.8% |
| Hiv Test Positive |
0.8% |
| Infection Prophylaxis |
0.7% |
| Diarrhoea |
0.6% |
| Neuropathy Peripheral |
0.6% |
|
| Vomiting |
14.3% |
| Weight Decreased |
12.4% |
| Death |
11.5% |
| Viral Load Increased |
6.7% |
| Myocardial Infarction |
6.5% |
| Drug Interaction |
4.8% |
| Pyrexia |
4.5% |
| Weight Increased |
4.2% |
| Rash |
3.9% |
| Neutropenia |
3.7% |
| Renal Failure Acute |
3.7% |
| Renal Failure |
3.4% |
| Sepsis |
3.4% |
| Tuberculosis |
3.4% |
| Rhabdomyolysis |
2.5% |
| Liver Disorder |
2.2% |
| Mental Status Changes |
2.2% |
| Nausea |
2.2% |
| No Therapeutic Response |
2.2% |
| Pneumonia |
2.2% |
|
| Interacting |
| Hiv Infection |
47.5% |
| Antiretroviral Therapy |
23.2% |
| Hodgkin's Disease |
4.6% |
| Neuropathy Peripheral |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Contraception |
2.3% |
| Alcohol Abuse |
1.9% |
| Antifungal Prophylaxis |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Hepatitis C |
1.5% |
| Unrelated Donor Bone Marrow Transplantation Therapy |
1.5% |
| Hypertension |
1.1% |
| Antiviral Prophylaxis |
0.8% |
| Ascites |
0.8% |
| Back Pain |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Hyperlipidaemia |
0.8% |
| Immunosuppression |
0.8% |
| Insomnia |
0.8% |
| Lipodystrophy Acquired |
0.8% |
|
| Drug Interaction |
23.1% |
| Nephrogenic Diabetes Insipidus |
7.7% |
| Neurotoxicity |
7.7% |
| Renal Failure Acute |
7.7% |
| Drug Metabolising Enzyme Test Abnormal |
5.1% |
| Herpes Simplex |
5.1% |
| Multi-organ Failure |
5.1% |
| Off Label Use |
5.1% |
| Viral Load Decreased |
5.1% |
| Drug Level Decreased |
2.6% |
| Ectopic Pregnancy |
2.6% |
| Fanconi Syndrome |
2.6% |
| Incorrect Drug Administration Duration |
2.6% |
| Intentional Overdose |
2.6% |
| Nephropathy Toxic |
2.6% |
| Overdose |
2.6% |
| Proteinuria |
2.6% |
| Renal Impairment |
2.6% |
| Renal Tubular Disorder |
2.6% |
| Rhabdomyolysis |
2.6% |
|
